CollPlant Biotechnologies Ltd. (ADR)

General ticker "CLGN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $20.6M (TTM average)

CollPlant Biotechnologies Ltd. (ADR) does not follow the US Stock Market performance with the rate: -26.0%.

Estimated limits based on current volatility of 8.3%: low 0.34$, high 0.40$

Factors to consider:

  • Total employees count: 39 as of 2017
  • Current price 62.3% below estimated low
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [1.14$, 3.20$]
  • 2026-12-31 to 2027-12-31 estimated range: [1.31$, 3.50$]

Financial Metrics affecting the CLGN estimates:

  • Positive: with PPE of -1.1 at the end of fiscal year the price was neutral
  • Negative: negative Operating cash flow
  • Positive: 42.57 < Shareholder equity ratio, % of 56.38 <= 64.23
  • Negative: negative Operating income
  • Positive: Interest expense per share per price, % of 0.08 <= 0.74
  • Positive: Investing cash flow per share per price, % of -0.15 > -0.60
  • Positive: Inventory ratio change, % of -26.61 <= -0.75
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: negative Net income

Similar symbols

Short-term CLGN quotes

Long-term CLGN plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $10.96MM $0.52MM $2.37MM
Operating Expenses $18.47MM $17.77MM $13.85MM
Operating Income $-7.51MM $-17.25MM $-11.48MM
Non-Operating Income $0.49MM $0.64MM $-0.01MM
Interest Expense $0.01MM $0.02MM $0.01MM
R&D Expense $10.48MM $10.52MM $8.19MM
Income(Loss) $-7.02MM $-16.61MM $-11.49MM
Net Income(Loss)* $-7.02MM $-16.61MM $-11.49MM
Stockholders Equity $28.34MM $13.46MM $6.08MM
Inventory $0.71MM $0.44MM $0.57MM
Assets $34.13MM $18.71MM $10.79MM
Operating Cash Flow $-2.76MM $-14.09MM $-9.42MM
Capital expenditure $0.95MM $0.48MM $0.03MM
Investing Cash Flow $-1.16MM $-0.54MM $-0.03MM
Financing Cash Flow $1.11MM $0.01MM $3.10MM
Earnings Per Share** $-0.62 $-1.45 $-0.94
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.